ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981

Gritz is president-elect of Society for Research on Nicotine and Tobacco.

September 23, 2005

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012